Orbimed Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 911,420 shares of XENE stock, worth $35.5 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

911,420

Previous 862,362 5.69%

Holding current value

$35.5 Million

Previous $33.6 Million 6.67%

% of portfolio

0.85%

Previous 0.81%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1.77 Million - $2.16 Million	49,058 Added 5.69%	911,420 $35.9 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $11.3 Million - $13.7 Million	312,362 Added 56.79%	862,362 $33.6 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $11.7 Million - $19 Million	-408,793 Reduced 42.64%	550,000 $25.3 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $4.69 Million - $5.45 Million	-137,207 Reduced 12.52%	958,793 $32.8 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $1.85 Million - $2.31 Million	-53,100 Reduced 4.62%	1,096,000 $42.2 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $390,108 - $465,274	11,800 Added 1.04%	1,149,100 $45.3 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $5.91 Million - $7.64 Million	-191,900 Reduced 14.44%	1,137,300 $41.1 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $16.4 Million - $22.6 Million	643,200 Added 93.76%	1,329,200 $40.4 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $1.38 Million - $1.82 Million	55,000 Added 8.72%	686,000 $21 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $2.4 Million - $5.45 Million	154,000 Added 32.29%	631,000 $19.7 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $12.7 Million - $16.7 Million	-857,217 Reduced 64.25%	477,000 $7.29 Million
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $19.6 Million - $23.3 Million	-1,163,700 Reduced 46.59%	1,334,217 $24.8 Million
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $8.53 Million - $12.4 Million	835,105 Added 50.22%	2,497,917 $31.3 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $8.31 Million - $18.1 Million	1,028,000 Added 161.94%	1,662,812 $18.9 Million
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $1.56 Million - $2.06 Million	634,812	634,812 $1.87 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Xenon Pharmaceuticals Inc. Transaction History